Identification of F5 as a Prognostic Biomarker in Patients with Gastric Cancer

Figure 5

Prognostic value of the F5 (231029_at) expression determined by the Kaplan-Meier plotter tool. Overall survival curves for (a) diffuse-type, (b) poor differentiation, (c) moderate differentiation, (d) HER2-negative, (e) HER2-positive, and (f) 5-Fu treatment gastric cancer. F5: Coagulation factor V.

(a)

(b)

(c)

(d)

(e)

(f)